Absorption, Metabolism and Excretion (AME) of Single Dose Radiolabeled Prucalopride Succinate in Volunteers
Status:
Completed
Trial end date:
2013-04-28
Target enrollment:
Participant gender:
Summary
Phase I study to evaluate the excretion of radioactivity, the metabolic profile,
pharmacokinetics, safety and tolerability following a single oral administration of [14C]
Prucalopride Succinate in healthy male volunteers aged 18 to 50 years (inclusive).The purpose
of this study is to investigate how and how quickly Prucalopride Succinate or its break down
products are excreted by analysing blood, faeces and urine samples collected during the
study.